RDTCF (Rapid Dose Therapeutics) 5-Year ROIIC % : -618.92% (As of Feb. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Rapid Dose Therapeutics 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Rapid Dose Therapeutics's 5-Year ROIIC % for the quarter that ended in Feb. 2024 was -618.92%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Rapid Dose Therapeutics's 5-Year ROIIC % or its related term are showing as below:

RDTCF's 5-Year ROIIC % is ranked worse than
89.71% of 1302 companies
in the Biotechnology industry
Industry Median: -22.27 vs RDTCF: -618.92

Rapid Dose Therapeutics 5-Year ROIIC % Historical Data

The historical data trend for Rapid Dose Therapeutics's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics 5-Year ROIIC % Chart

Rapid Dose Therapeutics Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

5-Year ROIIC %

Get a 7-Day Free Trial

-29.76

-618.92

Rapid Dose Therapeutics Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
5-Year ROIIC %	Get a 7-Day Free Trial															-	-	-618.92	-	-

Competitive Comparison of Rapid Dose Therapeutics's 5-Year ROIIC %

For the Biotechnology subindustry, Rapid Dose Therapeutics's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rapid Dose Therapeutics's 5-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's 5-Year ROIIC % falls into.

Rapid Dose Therapeutics 5-Year ROIIC % Calculation

Rapid Dose Therapeutics's 5-Year ROIIC % for the quarter that ended in Feb. 2024 is calculated as:

5-Year ROIIC %	=	5-Year Incremental Net Operating Profit After Taxes (NOPAT)^**	/	5-Year Incremental Invested Capital^**
	=	( -2.279 (Feb. 2024) - -8.693 (Feb. 2019) )	/	( 0.983 (Feb. 2024) - 2.034 (Feb. 2019) )
	=	6.414	/	-1.051
	=	-610.28%^***

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Rapid Dose Therapeutics (OTCPK:RDTCF) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.

Rapid Dose Therapeutics 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Dose Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (OTCPK:RDTCF) » Definitions » 5-Year ROIIC %

Comparable Companies

Traded in Other Exchanges

DOSE:Canada

Address

1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4

Website

https://www.rapid-dose.com

Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.